by EmpathiCSubstanceS | May 3, 2021 | Addiction, Alcoholism
In an incredible milestone, representing the ongoing legitimization of psychedelic science, a formal facility dedicated to the study of psychedelics has been launched at Imperial College London. While the newly established Centre for Psychedelics Research is not the...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana, CBC
Positive results from the world’s first clinical trial testing the potential for cannabidiol (CBD) to treat cannabis addiction suggest daily use of medical-grade CBD is both safe and effective at reducing problematic cannabis consumption. The researchers quickly...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
Research from Washington State University (WSU), and published in The Journal of Affective Disorders, is reporting some people find their symptoms of obsessive-compulsive disorder (OCD) dramatically drop after smoking cannabis. The study suggests the improvements may...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks. The preliminary trial was small, with follow-up work...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
New research from scientists at Stanford University School of Medicine suggests cannabis use can be linked to higher rates of “rebound headaches” in migraine sufferers. The research is observational and retrospective, but it is yet another...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
Cannabidiol, better known as CBD, is rapidly gaining popularity as a potion to treat almost every kind of medical concern you can think of, but scientific evidence is scant outside of a few clinically proven indications. A new study from a team of Canadian researchers...
